The economic conditions all around the globe have enhanced significantly over the past few months, which directly affected the financial figures reported by organizations. EKSO BIONICS HOLDING (OTCBB:EKSO) also announced the financial results for 2014. As per the reports, it proved to be a good financial year for the company as it managed to generate $2.9 million revenues in medical device segment, way more than a year ago.
While announcing the results, the entire management team of Ekso looked delighted. Nathan Harding, Co-Founder and Chief Executive Officer of Ekso, stated that the progress Ekso made in 2014 was truly appreciable but could never be possible had stakeholders not supported the company. All the employees, customers, and vendors kept their trust on Ekso, which has put company in a commendable position.
Highlights of 4Q2014:
Ekso managed to ship close to 64 devices in 4Q2014, which was 250% more than a year ago. After amazing performance in the previous year, the overall device numbers have now touched new heights. As per the reports, it has managed to acquire more than 80 customers through selling or renting out more than 110 devices so far.
The last three months of 2014 were quite good for the company. The total revenue for 4Q2014 was $1.5 million as compared to $0.8 million of 4Q2013. A major part of this year’s revenue was generated by selling medical devices. As per the reports, it made around $0.9 million from medical device sale in 4Q2014, more than $0.5 million that it made during 4Q2013. This considerable increment of $0.4 was due to the recognition of sale of certain medical devices as revenue
If taken into consideration the figures for the entire year, then medical device revenue sums up to $2.9 million as compared to $1.3 million of 2013. Management expects to take this figure to new heights by the end of the current year.